These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 26715033)

  • 1. Beta-1-Selective Beta-Blockers and Cognitive Functions in Patients With Coronary Artery Disease: A Cross-Sectional Study.
    Burkauskas J; Noreikaite A; Bunevicius A; Brozaitiene J; Neverauskas J; Mickuviene N; Bunevicius R
    J Neuropsychiatry Clin Neurosci; 2016; 28(2):143-6. PubMed ID: 26715033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing cognitive effects of anticholinergic medications in patients with coronary artery disease.
    Lanctôt KL; O'Regan J; Schwartz Y; Swardfager W; Saleem M; Oh PI; Herrmann N
    Psychosomatics; 2014; 55(1):61-8. PubMed ID: 23993643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Depression, Anxiety, and Type D Personality with Cognitive Function in Patients with Coronary Artery Disease.
    Burkauskas J; Brozaitiene J; Bunevicius A; Neverauskas J; Zaliunaite V; Bunevicius R
    Cogn Behav Neurol; 2016 Jun; 29(2):91-9. PubMed ID: 27336806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heart rate control in an unselected consecutive population of outpatients with stable coronary artery disease: Analysis of the CARDIf Study Cohort.
    Vitale C; Iellamo F; Volterrani M; Lombardi M; Fini M; Banach M; Rosano GM
    Angiology; 2010 Nov; 61(8):763-7. PubMed ID: 20462892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of beta-blocker therapy on mortality rates and future myocardial infarction rates in patients with coronary artery disease but no history of myocardial infarction or congestive heart failure.
    Bunch TJ; Muhlestein JB; Bair TL; Renlund DG; Lappé DL; Jensen KR; Horne BD; Carter MA; Anderson JL;
    Am J Cardiol; 2005 Apr; 95(7):827-31. PubMed ID: 15781009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metoprolol, a beta-1 selective blocker, can be used safely in coronary artery disease patients with chronic obstructive pulmonary disease.
    Camsari A; Arikan S; Avan C; Kaya D; Pekdemir H; Ciçek D; Kiykim A; Sezer K; Akkuş N; Alkan M; Aydoğdu S
    Heart Vessels; 2003 Sep; 18(4):188-92. PubMed ID: 14520486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pattern of use of β-blockers in older patients with stable coronary artery disease: an observational, cross-sectional, multicentre survey.
    Vitale C; Spoletini I; Volterrani M; Iellamo F; Fini M
    Drugs Aging; 2011 Sep; 28(9):703-11. PubMed ID: 21913736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of anxious and depressive symptoms with medication nonadherence in patients with stable coronary artery disease.
    Dempe C; Jünger J; Hoppe S; Katzenberger ML; Möltner A; Ladwig KH; Herzog W; Schultz JH
    J Psychosom Res; 2013 Feb; 74(2):122-7. PubMed ID: 23332526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First episode of major depressive disorder and vascular factors in coronary artery disease patients: Baseline characteristics and response to antidepressant treatment in the CREATE trial.
    Habra ME; Baker B; Frasure-Smith N; Swenson JR; Koszycki D; Butler G; van Zyl LT; Lespérance F
    J Psychosom Res; 2010 Aug; 69(2):133-41. PubMed ID: 20624511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A dynamic view of depressive symptoms and neurocognitive change among patients with coronary artery disease.
    Freiheit EA; Hogan DB; Eliasziw M; Patten SB; Demchuk AM; Faris P; Anderson T; Galbraith D; Parboosingh JS; Ghali WA; Knudtson M; Maxwell CJ
    Arch Gen Psychiatry; 2012 Mar; 69(3):244-55. PubMed ID: 22393217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. β-blocker use in patients after percutaneous coronary interventions: one size fits all? Worse outcomes in patients without myocardial infarction or heart failure.
    Ozasa N; Morimoto T; Bao B; Furukawa Y; Nakagawa Y; Kadota K; Iwabuchi M; Shizuta S; Shiomi H; Tazaki J; Natsuaki M; Kimura T;
    Int J Cardiol; 2013 Sep; 168(2):774-9. PubMed ID: 23127614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between mortality and persistent use of beta blockers and angiotensin-converting enzyme inhibitors in patients with left ventricular systolic dysfunction and coronary artery disease.
    Allen LaPointe NM; Zhou Y; Stafford JA; Hernandez AF; Kramer JM; Anstrom KJ
    Am J Cardiol; 2009 Jun; 103(11):1518-24. PubMed ID: 19463509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive performance in nondemented nonpsychotic Parkinson disease patients with or without a history of depression prior to the onset of motor symptoms.
    Klepac N; Hajnsek S; Trkulja V
    J Geriatr Psychiatry Neurol; 2010 Mar; 23(1):15-26. PubMed ID: 19996416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Musculoskeletal pain and related factors in coronary artery disease: An observational cross-sectional study.
    Sezgin Ozcan D; Koseoglu BF; Balci KG; Polat CS; Ozcan OU; Balci MM; Aydoğdu S
    J Back Musculoskelet Rehabil; 2018; 31(5):839-847. PubMed ID: 29865028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of physician concordance with guidelines on the perioperative use of beta-blockers.
    Siddiqui AK; Ahmed S; Delbeau H; Conner D; Mattana J
    Arch Intern Med; 2004 Mar; 164(6):664-7. PubMed ID: 15037496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. β-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease.
    Bangalore S; Steg G; Deedwania P; Crowley K; Eagle KA; Goto S; Ohman EM; Cannon CP; Smith SC; Zeymer U; Hoffman EB; Messerli FH; Bhatt DL;
    JAMA; 2012 Oct; 308(13):1340-9. PubMed ID: 23032550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. β-Blocker use in angiographic coronary artery disease patients without myocardial infarction or heart failure: a report from the ET-CHD registry, 1997-2006.
    Li YH; Lin GM; Lai CP; Lin CL; Wang JH
    Int J Cardiol; 2013 Oct; 168(5):4817-9. PubMed ID: 23871618
    [No Abstract]   [Full Text] [Related]  

  • 18. β-Blockers improve survival of patients with chronic obstructive pulmonary disease after coronary artery bypass grafting.
    Angeloni E; Melina G; Roscitano A; Refice S; Capuano F; Lechiancole A; Comito C; Benedetto U; Sinatra R
    Ann Thorac Surg; 2013 Feb; 95(2):525-31. PubMed ID: 23040827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inadequate heart rate control despite widespread use of beta-blockers in outpatients with stable CAD: findings from the international prospective CLARIFY registry.
    Tendera M; Fox K; Ferrari R; Ford I; Greenlaw N; Abergel H; Macarie C; Tardif JC; Vardas P; Zamorano J; Gabriel Steg P;
    Int J Cardiol; 2014 Sep; 176(1):119-24. PubMed ID: 25042656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Exercise Capacity with Physical Functionality and Various Aspects of Fatigue in Patients with Coronary Artery Disease.
    Nagy A; Szabados E; Simon A; Mezey B; Sándor B; Tiringer I; Tóth K; Bencsik K; Csathó Á
    Behav Med; 2018; 44(1):28-35. PubMed ID: 27223330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.